Is a fluciclovine (Axumin) PET scan an adequate imaging modality for prostate cancer re-staging after a biochemical failure?

Topics: Radiation Oncology • Genitourinary Cancers

Should a bone scan and/or MRI of the pelvis be obtained as well?

Answer from: Radiation Oncologist at Academic Institution

Fluciclovine (Axumin) [FACBC] PET scan was FDA approved in May 2016 for recurrent prostate cancer – FDA approval was based on high accuracy of PET uptake when correlating with biopsy. As with any diagnostic imaging test, Axumin has higher diagnostic yield with increasing PSA. While Axumin can ...

Comments

Medical Oncologist at Norton Cancer Institute
Would you be able to comment on the utility of thi...

Radiation Oncologist at Mon Health
Would you now order a PSMA scan instead?

Radiation Oncologist at Radiation Oncology of Atlanta
We have used Axumin PETCT since it was approved. M...

Related Questions